BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 28, 2026
Home » Blogs » BioWorld Perspectives » Sausage, the Law and Jello

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

Sausage, the Law and Jello

July 25, 2011
By Anette Breindl

Scientists at Beijing University of Chemical Technology have reported a way to express human-derived gelatin in yeast cells, and suggest that human-derived gelatin might be a useful alternative to pig-and cow derived gelatin for use in the food industry.

This, in turn, has set the blogosphere abuzz: Is it vegetarian? Cannibalistic? Just plain gross?

Some blogs have compared this to San Francisco company FibroGen Inc., which is making vaccine and biologics stabilizers. But medical uses seem different. I’m not sure what FibroGen intends to put into its gelatin capsules, but what if it’s a recombinant therapeutic protein? Does the yuck factor apply to the capsule, but not the protein? Are you diabetic and grateful for human recombinant insulin? There you go.

One way to get out of this conundrum is the food snob method: declare Jello itself inedible. A more frequent approach than you might think, but the way. During a lovely afternoon at this exhibit at the Massachusetts Museum of Contemporary Art last summer, I heard more than one parent explaining the concept of Jello to their child like this: “Well, you could eat that, but we don’t in our family.” (My heathens, for the record, knew exactly what Jello was long before they encountered arty short films of a Jello San Francisco falling prey to an earthquake/tsunami.)

In the end, this reminds me of the old saying about sausage and the law: those who respect one and like the other should never watch either one being made. The truth is, lots of things are like sausage and the law. Including, it seems, both medication and Jello.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 27, 2026.
  • Drug capsule spilling onto brain

    Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s

    BioWorld Science
    Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
  • Cell nucleus architecture

    4D Nucleome opens new wave of gene regulation research, discovery

    BioWorld
    After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
  • EMA logo on mobile screen, vials, syringes

    Daybu readthrough in EU? Zevra’s NPC bid flounders

    BioWorld
    Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
  • Business pipeline illustration

    Transcripta Bio raises funding to advance neuro pipeline

    BioWorld Science
    Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing